» Authors » Reinhart Speeckaert

Reinhart Speeckaert

Explore the profile of Reinhart Speeckaert including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 121
Citations 1449
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Speeckaert R, Duponselle J, Wolkerstorfer A, Speeckaert M, van Geel N
J Eur Acad Dermatol Venereol . 2025 Feb; PMID: 39902940
No abstract available.
2.
Speeckaert R, Belpaire A, Lambert J, Speeckaert M, van Geel N
Immune Netw . 2024 Nov; 24(5):e33. PMID: 39513029
In recent years, there have been significant breakthroughs in the identification of immunological components of skin diseases and in the development of immunomodulatory drugs. Novel therapies create exciting prospects for...
3.
Speeckaert R, Speeckaert M, van Geel N
Antioxidants (Basel) . 2024 Sep; 13(9). PMID: 39334740
Different tissues experience various levels of oxidative stress based on their function and protection from outside environments [...].
4.
Speeckaert R, Caelenberg E, Belpaire A, Speeckaert M, van Geel N
J Clin Med . 2024 Sep; 13(17). PMID: 39274437
Recent advances in vitiligo have provided promising treatment options, particularly through understanding the immune-mediated mechanisms leading to depigmentation. The inflammatory components in both vitiligo (non-segmental) and segmental vitiligo have similarities....
5.
Delrue C, Speeckaert R, Moresco R, Speeckaert M
Int J Mol Sci . 2024 Sep; 25(17). PMID: 39273390
Chronic kidney disease (CKD) is characterized by a steady decline in kidney function and affects roughly 10% of the world's population. This review focuses on the critical function of cyclic...
6.
Delbaere L, Duponselle J, Herbelet S, Speeckaert R, van Geel N
Exp Dermatol . 2024 Sep; 33(9):e15167. PMID: 39246295
The progression of vitiligo is unpredictable, emphasizing the need to identify periods of activity early for tailored treatment. Confetti-like depigmentation, hypochromic areas/borders and Koebner's phenomenon are clinical visible signs associated...
7.
Reinhart S, Speeckaert R, Lu W, Wang L, Nanja V, van Geel N
Clin Exp Dermatol . 2024 Aug; 50(2):446-448. PMID: 39172556
No abstract available.
8.
Delrue C, Speeckaert R, Delanghe J, Speeckaert M
Vitam Horm . 2024 Jul; 125:311-365. PMID: 38997169
Advanced glycation end products (AGEs) are compounds formed via non-enzymatic reactions between reducing sugars and amino acids or proteins. AGEs can accumulate in various tissues and organs and have been...
9.
Delrue C, Speeckaert R, Delanghe J, Prytula A, Speeckaert M
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892458
Vitamin D-binding protein (DBP), also known as Gc-globulin, is a protein that affects several physiological processes, including the transport and regulation of vitamin D metabolites. Genetic polymorphisms in the gene...
10.
Delrue C, De Bruyne S, Oyaert M, Delanghe J, Moresco R, Speeckaert R, et al.
Int J Mol Sci . 2024 Jun; 25(11). PMID: 38892184
The early detection of gynecological cancers, which is critical for improving patient survival rates, is challenging because of the vague early symptoms and the diagnostic limitations of current approaches. This...